BR0212205A - Uso de dióis ou dionas de pregnano como agentes analgésicos neuropáticos - Google Patents

Uso de dióis ou dionas de pregnano como agentes analgésicos neuropáticos

Info

Publication number
BR0212205A
BR0212205A BR0212205-7A BR0212205A BR0212205A BR 0212205 A BR0212205 A BR 0212205A BR 0212205 A BR0212205 A BR 0212205A BR 0212205 A BR0212205 A BR 0212205A
Authority
BR
Brazil
Prior art keywords
diones
diols
analgesic agents
pregnane
neuropathic
Prior art date
Application number
BR0212205-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Colin Stanley Goodchild
Raymond Nadeson
Original Assignee
Univ Monash
Colin Stanley Goodchild
Raymond Nadeson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash, Colin Stanley Goodchild, Raymond Nadeson filed Critical Univ Monash
Publication of BR0212205A publication Critical patent/BR0212205A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR0212205-7A 2001-08-28 2002-08-28 Uso de dióis ou dionas de pregnano como agentes analgésicos neuropáticos BR0212205A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR7319A AUPR731901A0 (en) 2001-08-28 2001-08-28 Method of treatment
PCT/AU2002/001144 WO2003018027A1 (en) 2001-08-28 2002-08-28 Use of pregnane-diones or diols as neuropathic analgesic agents

Publications (1)

Publication Number Publication Date
BR0212205A true BR0212205A (pt) 2004-09-21

Family

ID=3831271

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212205-7A BR0212205A (pt) 2001-08-28 2002-08-28 Uso de dióis ou dionas de pregnano como agentes analgésicos neuropáticos

Country Status (10)

Country Link
US (2) US20050009796A1 (enExample)
EP (1) EP1450817A4 (enExample)
JP (1) JP2005504776A (enExample)
CN (2) CN1549719A (enExample)
AU (2) AUPR731901A0 (enExample)
BR (1) BR0212205A (enExample)
CA (1) CA2468466A1 (enExample)
MX (1) MXPA04001807A (enExample)
RU (1) RU2346690C2 (enExample)
WO (1) WO2003018027A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
GB0324423D0 (en) * 2003-10-18 2003-11-19 Vernalis Cambridge Ltd Analgesia method
WO2006010085A1 (en) * 2004-07-09 2006-01-26 Roxro Pharma, Inc. Use of neurosteroids to treat neuropathic pain
RU2306929C1 (ru) * 2005-12-28 2007-09-27 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции комбинацией индапамида и l-аргинина при l-name-индуцированном дефиците оксида азота
RU2302241C1 (ru) * 2005-12-28 2007-07-10 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции комбинацией индапамида и резвератрола при l-name-индуцированном дефиците оксида азота
RU2306924C1 (ru) * 2005-12-28 2007-09-27 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции комбинацией лозартана и резвератрола при l-name-индуцированном дефиците оксида азота
RU2306930C1 (ru) * 2005-12-28 2007-09-27 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции комбинацией лозартана и l-аргинина при l-name-индуцированном дефиците оксида азота
RU2296566C1 (ru) * 2005-12-28 2007-04-10 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции комбинацией амлодипина и l-аргинина при l-name-индуцированном дефиците оксида азота
US20110008431A1 (en) * 2007-04-02 2011-01-13 Toyo Boseki Kabushiki Kaisha Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
RU2364393C1 (ru) * 2008-03-19 2009-08-20 Михаил Владимирович Покровский Способ коррекции эндотелиальной дисфункции пикамилоном при l-name индуцированном дефиците оксида азота
WO2010025316A1 (en) * 2008-08-29 2010-03-04 Jeffrey Comanor Composition and methods for relief of neuropathological pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
GB1373913A (en) * 1970-12-17 1974-11-13 Glaxo Lab Ltd Pharmaceutical compositions
US5888996A (en) * 1995-07-26 1999-03-30 Trustees Of Boston University Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity
EP0840612A1 (en) * 1995-07-24 1998-05-13 Trustees Of Boston University Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
AUPN498095A0 (en) * 1995-08-23 1995-09-14 Goodchild, Colin Stanley Compounds and compositions
GB9607034D0 (en) * 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
US6048848A (en) * 1996-08-23 2000-04-11 Monash University Use of pregnane-diones as analgesic agents
US6787530B1 (en) * 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
ATE425459T1 (de) * 1999-08-31 2009-03-15 Univ Boston Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent

Also Published As

Publication number Publication date
WO2003018027A1 (en) 2003-03-06
US20050009796A1 (en) 2005-01-13
EP1450817A1 (en) 2004-09-01
RU2346690C2 (ru) 2009-02-20
CA2468466A1 (en) 2003-03-06
CN101590062A (zh) 2009-12-02
JP2005504776A (ja) 2005-02-17
EP1450817A4 (en) 2009-02-25
AUPR731901A0 (en) 2001-09-20
RU2004109517A (ru) 2005-06-27
MXPA04001807A (es) 2005-03-07
CN1549719A (zh) 2004-11-24
AU2008202729A1 (en) 2008-07-17
US20080227764A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
DE60140383D1 (de) Zementdispergiermittel und dieses enthaltende Zementzusammensetzung
BR0111878A (pt) N-ureido-(heterociclo-alquil)-piperidinas como moduladores da atividade de receptores de quimiocinas
ATE507834T1 (de) Sarsasapogenin und smilagenin zur behandlung kognitiver störungen
EP1402053A4 (en) CHDS AS MODULATORS OF THE P53 PATH AND METHOD OF USE
PT1353689E (pt) Composicoes imunizantes e metodos de utilizacao
PT1246835E (pt) Sapogeninas substituídas e sua utilização
EP2033965A3 (en) 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
NI200700331A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
CL2004000026A1 (es) Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino.
BRPI0417343A (pt) antagonistas do receptor muscarìnico m3 de acetilcolina
BR0114912A (pt) Kahalalide f
EP1768653A4 (en) METHOD AND COMPOSITIONS FOR TREATING ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY AND HYPERPHENYL ALANINEMIA
PT9800U (pt) Mosquiteiro com dispositivo de encaixe e desencaixe rapido da barra do puxador
DE60334726D1 (de) Dendrimerkonjugate für selektive lösung von proteinaggregaten
DE50205129D1 (de) 8-tetradecenal als duft- oder aromastoff
EP1450817A4 (en) USE OF PREGNAN DIONES OR DIOLES AS NEUROPATHIC ANALGETICS
ATE205217T1 (de) Steroide als mittel zur kontrazeption und gegen osteoporose
BR0207839A (pt) Composição de limpeza pessoal
BR0110450A (pt) Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
BR0115450A (pt) Métodos de extinção de fogo utilizando hidrofluoroéteres
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
AR059789A1 (es) "dominios kunitz quimericos y su uso "
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
EP1602723A4 (en) METHOD FOR THE STUDY OF OBESITY AND EXCEPTION

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.